In addition, the induction of long-term protective immunity against tumors appears to require concerted recognition of tumor antigens by memory CD4+ and CD8+ T cells, and this may be best achieved by treatment with cancer vaccines plus OV [65]. This evidence concerns the gene CD8A and neoplasm.